Loading...
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
IBIO
IBIO News & Events
-
Add to Watchlist
Trade IBIO
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Forecast
Technical
Valuation
Financials
Earnings
Should I Buy
News
IBIO News
After-Hours Stock Surge: Exicure Leads with 72% Increase, Followed by Wave Life and Assembly Biosciences
Dec 09 2025
NASDAQ.COM
iBio Reveals Promising Non-Human Primate Data for IBIO-610, an Activin E Antibody with Significant Potential for Targeted Weight Loss and Maintenance
Oct 30 2025
Newsfilter
iBio to Attend the 2nd Annual Healthcare Innovation Conference Hosted by Guggenheim
Oct 23 2025
Newsfilter
VTYX, MEDP, INBX Surge in After-Hours Trading Following Important Announcements
Oct 23 2025
NASDAQ.COM
iBio to Showcase New Preclinical Findings on Its Activin E Antibody at ObesityWeek® and PEGS Europe 2025 Conferences
Oct 21 2025
Newsfilter
Leerink Partners Begins Coverage of iBio with Outperform Rating and Sets Price Target at $2
Oct 17 2025
Benzinga
Serina Therapeutics Stock Rises Over 25%; Check Out 20 Stocks Making Moves in Premarket Trading
Aug 26 2025
Benzinga
IBio Launches $50 Million Public Offering to Support Preclinical Antibody Initiatives
Aug 20 2025
NASDAQ.COM
Show More News
IBIO Events
01/20 12:10
ImmunityBio Stock Rises 27.5% to $7.04
ImmunityBio is up 27.5%, or $1.52 to $7.04.
01/20 10:10
ImmunityBio Stock Rises 25.3% to $6.92
ImmunityBio is up 25.3%, or $1.40 to $6.92.
01/19 10:10
ImmunityBio Stock Rises 39.7% to $5.52
ImmunityBio is up 39.7%, or $1.57 to $5.52.
Show More Events
IBIO Monitor News
iBio Inc rises 14.26% amid sector rotation.
Jan 09 2026
iBio Inc surges 26.06% amid market strength
Jan 06 2026
iBio Inc falls 22.73% amid market decline
Dec 12 2025
iBio Inc Hits 20-Day High Amid Market Weakness
Dec 10 2025
iBio Inc Hits 20-Day High Amid Market Gains
Dec 09 2025
iBio Inc Hits 20-Day High Amid Market Gains
Dec 08 2025
IBIO Earnings Analysis
No Data
People Also Watch